Karl P. Flora - Concepedia

Author

Karl P. Flora

National Cancer Institute

Also Known As

K Flora, K P Flora, K. Flora, K. P. Flora, K.P. Flora, KP Flora, Karl Flora, Karl P Flora, Karl P. Flora

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

National Cancer Institute National Cancer Institute National Institutes of Health University of California San Diego Medical Center Memorial Sloan Kettering Cancer Center

About

Karl P. Flora is an author at National Cancer Institute specializing in medicine, pharmacology, and chromatography.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	19	867
2	Natural Sciences	7	7	364
3	Engineering	3	3	70
4	Health Sciences	1	1	15
5	Anesthesia	1	1	14

Karl P. Flora

Publications

935

Citations

H-Index

Page 1

	Year	Citations
Taxol: a history of pharmaceutical development and current pharmaceutical concerns. Jonathan D. Adams, Karl P. Flora, Barry R. Goldspiel, PubMed Medicinal ChemistryPharmaceutical SciencePharmaceutical ResearchBiochemistryAntiparasitic Agent	1993	159
Initial studies on the cellular pharmacology of 2′,3′-dideoxyinosine, an inhibitor of HIV infectivity Gurpreet S. Ahluwalia, David A. Cooney, Hiroaki Mitsuya, Biochemical Pharmacology Molecular PharmacologyHiv InfectivityMedicineAntiviral Drug DevelopmentAntiviral Therapy	1987	147
Stability studies: five years later. Lawrence A. Trissel, Karl P. Flora PubMed BioequivalenceStability StudiesPharmacologyPatient SafetyHospital Pharmacy	1988	80
Stability of cisplatin, iproplatin, carboplatin, and tetraplatin in commonly used intravenous solutions Yuen-Wah Cheung, James C. Cradock, B. Rao Vishnuvajjala, American Journal of Health-System Pharmacy Intravenous SolutionsPharmaceutical ScienceSodium Chloride ConcentrationsPharmacotherapyMedicinal Chemistry	1987	66
Protein binding of human immunodeficiency virus protease inhibitor KNI-272 and alteration of its in vitro antiretroviral activity in the presence of high concentrations of proteins Seiji Kageyama, Barry Anderson, Barbara L. Hoesterey, Antimicrobial Agents and Chemotherapy High ConcentrationsImmunologyAntiviral DrugHuman Immunodeficiency VirusHuman Retrovirus	1994	63
Pharmacokinetics of 2',3' -dideoxyinosine in patients with severe human immunodeficiency infection. II. The effects of different oral formulations and the presence of other medications Neil R. Hartman, Robert Yarchoan, James M. Pluda, Clinical Pharmacology & Therapeutics	1991	55
Application of a simple high—performance liquid chomatographic method for the determination of melphalan in the presence of its hydrolysis products Karl P. Flora, Saralyn Smith, James C. Cradock Journal of Chromatography A Food ChemistryHydrolysis ProductsAnalytical ChemistryLiquid ChromatographyDermatology	1979	43
Myelotoxic effects of the bifunctional alkylating agent bizelesin on human, canine and murine myeloid progenitor cells Donna A. Volpe, Joseph E. Tomaszewski, Ralph E. Parchment, Cancer Chemotherapy and Pharmacology Hematological MalignancyMyelotoxic EffectsMedicineImmunologyHematology	1996	43
Stability Studies: Five years Later Lawrence A. Trissel, Karl P. Flora American Journal of Health-System Pharmacy EngineeringChemoprevention StrategyDevelopmental Therapeutics ProgramPre-clinical PharmacologyStability	1988	43
Pharmaceutical Development of (Investigational) Anticancer Agents for Parenteral Use-A Review Jantine D. Jonkman-de Vries, Karl P. Flora, A. Bult, Drug Development and Industrial Pharmacy Pharmaceutical SciencePharmacotherapyAnticancer AgentsPharmaceutical ChemistryFormulation Development Process	1996	37

Page 1